Swedish Orphan Biovitrum (OTCMKTS:BIOVF – Get Free Report) saw unusually-strong trading volume on Tuesday . Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Swedish Orphan Biovitrum in a report on Tuesday, July 21st. Zacks Research raised shares of Swedish Orphan Biovitrum to a “hold” rating in a research report on Thursday, May 7th. As a group, sell-side analysts expect that Swedish Orphan Biovitrum will post 1.94 earnings per share for the current year. Further ReadingReceive News & Ratings for Swedish Orphan Biovitrum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swedish Orphan Biovitrum and related companies with MarketBeat.com's FREE daily email newsletter.